New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 14, 2014
10:25 EDTEWEdwards Lifesciences rises sharply following court action, upgrades
The stock is up 13.6% to $82.97 following a U.S. District Court preliminary injunction that limits sales of Medtronic's (MDT) CoreValve system in the United States. JPMorgan and CRT Capital upgraded the name to Neutral and Buy, respectively. Wells Fargo upped its price target to $90 to $91. At current price the next major resistance level is at $86.11, the 52-week high. Support is at $81.93, the opening price of the day.
News For EW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 13, 2014
07:37 EDTEWAmerican Society of Anesthesiologists to hold annual meeting
Subscribe for More Information
October 6, 2014
07:56 EDTEWEdwards Lifesciences consensus estimates 'far too low,' says Leerink
Subscribe for More Information
07:26 EDTEWEdwards Lifesciences target raised to $121-$122 from $94-$95 at Wells Fargo
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use